Literature DB >> 27793586

Development of a genetically engineered Escherichia coli strain for plasmid transformation in Corynebacterium glutamicum.

Hedan Li1, Lirong Zhang2, Wei Guo3, Daqing Xu4.   

Abstract

Gene disruption and replacement in Corynebacterium glutamicum is dependent upon a high transformation efficiency. The cglIR-cgIIR restriction system is a major barrier to introduction of foreign DNA into Corynebacterium glutamicum cells. To improve the transformation efficiency of C. glutamicum, the cglIM gene encoding methyltransferase in the cglIR-cglIIR-cglIM restriction-modification system of C. glutamicum ATCC 13032 was chromosomally integrated and expressed in Escherichia coli, resulting in an engineered strain E. coli AU1. The electro-transformation experiments of C. glutamicum ATCC 13032 with the E. coli-C. glutamicum shuttle plasmid pAU4 showed that the transformation efficiency of C. glutamicum with pAU4 DNA extracted from E. coli TG1/pAU4 was 1.80±0.21×102cfu/μg plasmid DNA, while using pAU4 DNA extracted from E. coli AU1/pAU4, the transformation efficiency reached up to 5.22±0.33×106cfu/μg plasmid DNA. The results demonstrated that E. coli AU1 is able to confer the cglIM-specific DNA methylation pattern to its resident plasmid, which makes the plasmid resistant to the cglIR-cglIIR restriction and efficiently transferred into C. glutamicum. E. coli AU1 is a useful intermediate host for efficient transformation of C. glutamicum. Copyright Â
© 2016. Published by Elsevier B.V.

Entities:  

Keywords:  Corynebacterium glutamicum; Intermediate host; Plasmid transformation; cglIM-specific DNA methylation

Mesh:

Substances:

Year:  2016        PMID: 27793586     DOI: 10.1016/j.mimet.2016.10.019

Source DB:  PubMed          Journal:  J Microbiol Methods        ISSN: 0167-7012            Impact factor:   2.363


  3 in total

1.  Mutations in Peptidoglycan Synthesis Gene ponA Improve Electrotransformation Efficiency of Corynebacterium glutamicum ATCC 13869.

Authors:  Jiao Liu; Yu Wang; Yujiao Lu; Xiaomeng Ni; Xuan Guo; Jing Zhao; Jiuzhou Chen; Taiwo Dele-Osibanjo; Ping Zheng; Jibin Sun; Yanhe Ma
Journal:  Appl Environ Microbiol       Date:  2018-11-30       Impact factor: 4.792

2.  Bone morphogenetic protein-2 exhibits therapeutic benefits for osteonecrosis of the femoral head through induction of cartilage and bone cells.

Authors:  Chunhui Wang; Huimei Zang; Dongsheng Zhou
Journal:  Exp Ther Med       Date:  2018-03-09       Impact factor: 2.447

3.  The optimization system for preparation of TG1 competent cells and electrotransformation.

Authors:  Dafei Chai; Gang Wang; Lin Fang; Huizhong Li; Shanshan Liu; Haiying Zhu; Junnian Zheng
Journal:  Microbiologyopen       Date:  2020-05-11       Impact factor: 3.139

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.